Author
Listed:
- Michele Vigolo
(University of Lausanne)
- Melissa G. Chambers
(Harvard Medical School)
- Laure Willen
(University of Lausanne)
- Dehlia Chevalley
(University of Lausanne)
- Klaus Maskos
(Proteros Biostructures GmbH)
- Alfred Lammens
(Proteros Biostructures GmbH)
- Aubry Tardivel
(University of Lausanne)
- Dolon Das
(University of Lausanne)
- Christine Kowalczyk-Quintas
(University of Lausanne)
- Sonia Schuepbach-Mallepell
(University of Lausanne)
- Cristian R. Smulski
(University of Lausanne)
- Mahya Eslami
(University of Lausanne)
- Antonius Rolink
(University of Basel)
- Edith Hummler
(University of Lausanne)
- Eileen Samy
(EMD Serono Research & Development Institute)
- Yves Fomekong Nanfack
(EMD Serono Research & Development Institute)
- Fabienne Mackay
(Monash University)
- Maofu Liao
(Harvard Medical School)
- Henry Hess
(Merck KGaA)
- Xuliang Jiang
(EMD Serono Research & Development Institute)
- Pascal Schneider
(University of Lausanne)
Abstract
The B cell survival factor (TNFSF13B/BAFF) is often elevated in autoimmune diseases and is targeted in the clinic for the treatment of systemic lupus erythematosus. BAFF contains a loop region designated the flap, which is dispensable for receptor binding. Here we show that the flap of BAFF has two functions. In addition to facilitating the formation of a highly active BAFF 60-mer as shown previously, it also converts binding of BAFF to TNFRSF13C (BAFFR) into a signaling event via oligomerization of individual BAFF-BAFFR complexes. Binding and activation of BAFFR can therefore be targeted independently to inhibit or activate the function of BAFF. Moreover, structural analyses suggest that the flap of BAFF 60-mer temporarily prevents binding of an anti-BAFF antibody (belimumab) but not of a decoy receptor (atacicept). The observed differences in profiles of BAFF inhibition may confer distinct biological and clinical efficacies to these therapeutically relevant inhibitors.
Suggested Citation
Michele Vigolo & Melissa G. Chambers & Laure Willen & Dehlia Chevalley & Klaus Maskos & Alfred Lammens & Aubry Tardivel & Dolon Das & Christine Kowalczyk-Quintas & Sonia Schuepbach-Mallepell & Cristia, 2018.
"A loop region of BAFF controls B cell survival and regulates recognition by different inhibitors,"
Nature Communications, Nature, vol. 9(1), pages 1-15, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03323-8
DOI: 10.1038/s41467-018-03323-8
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03323-8. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.